Skip to content
Screener

OrthoPediatrics KIDS Income Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
$72.66M+18.6%$70.51M+15.4%$59.36M+13.3%$61.61M+17.0%$61.25M+12.2%
$18.69M+17.0%$18.14M+6.3%$15.97M+12.9%$16.5M-3.5%$15.98M+10.1%
$53.98M+19.2%$52.37M+19.0%$43.39M+13.4%$45.11M+26.8%$45.27M+13.0%
74.3%+0.4pp74.3%+2.2pp73.1%+0.1pp73.2%+5.7pp73.9%+0.5pp
$2.47M+5.7%$2.33M+7.7%$2.23M-5.1%$2.26M-22.5%$2.33M-9.5%
$23.1M+23.8%$21.29M+11.5%$18.47M+11.5%$18.4M+9.6%$18.65M+11.4%
$32.03M+9.9%$32.81M+7.8%$31.02M+2.5%$29.95M+22.6%$29.16M+10.9%
$58.2M+6.4%$56.43M+3.2%$51.73M+5.0%$53.28M+7.4%$54.7M+19.9%
-$4.23M+55.2%-$4.07M+61.8%-$8.34M+24.1%-$8.17M+41.9%-$9.43M-69.4%
-5.8%+9.6pp-5.8%+11.7pp-14%+6.9pp-13.3%+13.4pp-15.4%-5.2pp
$2.62M+43.6%$2.53M+127%$2.1M+86.7%$1.93M+46.5%$1.82M+351%
-$1.81M+26.6%-$2.86M-180%-$2.52M-587%——-$2.47M+30.8%
-$6.04M+49.2%-$6.93M+1.9%-$10.86M-3.8%-$9.76M+40.5%-$11.9M-30.2%
-$109K+12.8%$234K+378%-$171K-187%$340K+200%-$125K+89.7%
-$5.93M+49.6%-$7.16M-0.7%-$10.69M-0.3%-$10.1M+37.1%-$11.77M-48.7%
-8.2%+11.1pp-10.2%+1.5pp-18%+2.3pp-16.4%+14.1pp-19.2%-4.7pp
-$0.25+50.0%-$0.300.0%-$0.45+2.2%-$0.43+38.6%-$0.50-47.1%
$1.4M+134%$1.64M+130%-$2.61M+55.9%-$2.57M+74.5%-$4.13M-1,344%
1.9%+8.7pp2.3%+11.3pp-4.4%+6.9pp-4.2%+14.9pp-6.7%-6.2pp
-$4.23M+55.2%-$4.07M+61.8%-$8.34M+24.1%-$8.17M+41.9%-$9.43M-69.4%

FAQ

What is OrthoPediatrics's revenue?
OrthoPediatrics (KIDS) generated $264.1M in revenue over the trailing twelve months, up 16.2% year over year.
Is OrthoPediatrics profitable?
OrthoPediatrics is not currently profitable: it reported a net loss of $33.9M over the trailing twelve months, a -12.8% net margin.
What are OrthoPediatrics's profit margins?
Gross margin is 73.8% and operating margin is -9.4%, with a -12.8% net margin.
What is OrthoPediatrics's earnings per share?
OrthoPediatrics's diluted EPS over the trailing twelve months is $-1.43.
Where does OrthoPediatrics's income statement data come from?
Every line is extracted from OrthoPediatrics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.